IRLAB launches new website
IRLAB announced today that a new website, www.irlab.se, has been launched. The new website provides the market with clearer information about IRLAB and its operations. This is one of several preparatory activities that IRLAB carries out ahead of the planned move to the Nasdaq Stockholm Main Market during 2020.
Nicholas Waters, CEO at IRLAB, commented “We launch a new website with new technical functionality and broadened information about our business and the drug development projects the company is running. Our goal during 2020 is to apply for and list the company’s share on the Nasdaq Stockholm Main Market. Both the launch of the website and the share issue the company carries out during February are important steps in this process.”
IRLAB was listed on the Nasdaq Stockholm Premier Growth Market on February 28, 2017.